SlideShare a Scribd company logo
Vector control research needs for NTDs
Dr Raman Velayudhan,
Coordinator,
Vector Ecology and Management, NTD
Challenges of Vector Control
 Lack of resources
 Very often used as a last resort
Equipment's and plans are developed after the outbreak is
underway
A delay of over a week makes control ineffective
 Decentralization of health services
Trained staff
Procurement of appropriate interventions
Lack of routine vector surveillance
 Urban vector control
Delivery/Responsibility
Community involvement
Often blamed for failure
Aedes aegypti and Aedes albopictus
Knowledge & Research Gaps for Dengue Vector
Control
• Why is disease burden increasing?
Unsuccessful programs: Lack of resources, lack of political will or
ineffective implementation
Also responsible: Deficiencies in understanding virus transmission,
methods for assessing & responding to risk & failure to effectively use
surveillance data for control decisions
Knowledge & research gaps:
• Entomological measures of risk
• Epidemiologic impact of vector interventions
• Insecticide resistance: monitor & manage
• Spatial scales that characterize transmission
• Dynamic responses to control
• Research design for VC
Urban, semi-urban and rural movement
• Human movement –
critical and understudied
component in
transmission
• Facilitate identification of
hot spots, prompt
response and suppress
outbreaks
• Surveillance, intervention
and prevention
• Points of entry needs to
be monitored for vectors
under IHR (2005)
A Critical Assessment of Vector Control
for Dengue Prevention
NL Achee, F Gould, TA Perkins, RC Reiner, Jr., AC
Morrison, S Richie, DJ Gubler, and TW Scott
HAT and vector
• Vector borne disease, transmitted by glossina genus (tsetse fly)
• Main species involved:
• Gambiense HAT: G. palpalis, G. fuscipes
• Rhodesiense HAT: G. morsitans, G. fuscipes, G. pallidipes, G. Swynnetoni
HAT vector control
• Multiple vector control methods available, to be adapted to different
epidemiological settings
Ground spraying
Aerial spraying
Sterile insects release
Mobile baits
Natural baits
Protective fences
Artificial baits
Repellents
Rhodesiense HAT and vector control
• Rhodesiense HAT is a zoonotic disease where wildlife and
domestic animals are the main reservoirs. Vector control
and treatment of infected animals when possible are key
elements for controlling the disease.
• Vector control has successfully used in some Rhodesian
HAT foci. Successes were achieved through large-scale
operations, expensive and requiring strong vector control
departments
• Current vector control tools are highly variable in
characteristics and quality (Fabrics, colors, insecticide
loading and release,…). Target product profiles of these
tools tailored to different environments are needed.
• It is needed to improve the evidence-based knowledge for
countries to make decisions on which tools to use in
different settings, and how to use them most effectively.
Elimination of intra-domiciliary vectorial transmission of Chagas disease
in Latin America (2020)
Control of vectorial
transmission by August 2015
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
WHO1960
WHO1976
WHO1981
PAHO1984
Walsh1984
WHO1985
WHO1990
WHO1991
WHO1992
PAHO1994
Schmunis1999
Schmunis1999
Schmunis2000
WorlBank/DCPP2006
PAHO/WHO2006
WHO2010
WHO2013
WHO2014
Series1
Latin
American
Initiatives
Non endemic coutries
Initiative
• 3 hot control areas remaining: Gran Chaco, El Salvador/Guatemala & Amazon basin
Network to monitor triatomine bug resistance to
insecticides – REMOT
What tools/approaches are available for tackling exophilic
and exophagic sandflies?
1. Treating other main sources of bloodmeals with
systemic insecticides (endectocides), such as fipronil
and imidacloprid.
2. Exploiting sugar-feeding behaviour of vectors to
develop attractive toxic sugar baits (ATSBs)
3. Environmental Control
4. Developing insecticide-impregnated or repellent-
impregnated products to be used by specific
communities.
5. Pheromones?
6. Genetic Control? (e.g. SIT: sterile insect technique)
Integrated Vector Management
A rational decision-making process for
optimal use of resources for vector control
How do we operationalize IVM?
Framework for planning & implementation
2. Selection of
vector control
methods
3. Needs &
resources
4. Implementation
5. Monitoring
& evaluation
Disease situation
• Integrated surveillance
Vector, cases, lab
• Vector assessment
• Epidemiological assessment
• Stratification
• Local determinants of disease
Diseases specific
reporting needs
Conclusion
 Current tools & strategies have not been evaluated
adequately for disease impact (epidemiologic outcomes)
 There is current research on new tools/strategies, but little
support for improving delivery & coverage of vector control
 The biggest gap in current vector control for is how much
coverage is necessary for disease reduction goals
 General consensus is that 1 approach will not solve the
problem by itself, we need to use a combination of
approaches
 Vector control & vaccines: How exactly should this be done?
 Urban health and delivery of services needs to be addressed
 Sustained vector control interventions needs to be promoted

More Related Content

What's hot

DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
Philippine Hospital Infection Contol Nurses Associaton (PHICNA) Inc.
 
Smart-trap design and deployment strategies
Smart-trap design and deployment strategiesSmart-trap design and deployment strategies
Smart-trap design and deployment strategies
Plant Biosecurity Cooperative Research Centre
 
Epidemiology and Hand Hygiene
Epidemiology and Hand HygieneEpidemiology and Hand Hygiene
Epidemiology animal disease
Epidemiology   animal diseaseEpidemiology   animal disease
Epidemiology animal disease
b.stev
 
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
EuFMD
 
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health Examples
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health ExamplesDr. Lauri Hicks - One Health Antibiotic Stewardship Human Health Examples
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health Examples
John Blue
 
Formulating Institutional Antibiotic Policy
Formulating Institutional Antibiotic PolicyFormulating Institutional Antibiotic Policy
Formulating Institutional Antibiotic Policy
Philippine Hospital Infection Control Society
 
Outbreak Investigation of Healthcare Associated Infections
Outbreak Investigation of Healthcare Associated InfectionsOutbreak Investigation of Healthcare Associated Infections
Outbreak Investigation of Healthcare Associated Infections
Philippine Hospital Infection Contol Nurses Associaton (PHICNA) Inc.
 
The WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDsThe WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDs
Philippine Hospital Infection Control Society
 
Infection Control and Antibiotic Stewardship
Infection Control and Antibiotic StewardshipInfection Control and Antibiotic Stewardship
Infection Control and Antibiotic Stewardship
The CRUDEM Foundation
 
Antimicrobial Stewardship Program
Antimicrobial Stewardship ProgramAntimicrobial Stewardship Program
Antimicrobial Stewardship Program
saskohc
 
The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...
The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...
The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...
Philippine Hospital Infection Control Society
 
Using one health and participatory epidemiology to assess impacts of anthrax ...
Using one health and participatory epidemiology to assess impacts of anthrax ...Using one health and participatory epidemiology to assess impacts of anthrax ...
Using one health and participatory epidemiology to assess impacts of anthrax ...
ILRI
 

What's hot (16)

DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
DOH Antimicrobial Stewardship Program in Hospitals Manual of Procedures (MOP)...
 
Smart-trap design and deployment strategies
Smart-trap design and deployment strategiesSmart-trap design and deployment strategies
Smart-trap design and deployment strategies
 
Epidemiology and Hand Hygiene
Epidemiology and Hand HygieneEpidemiology and Hand Hygiene
Epidemiology and Hand Hygiene
 
Epidemiology animal disease
Epidemiology   animal diseaseEpidemiology   animal disease
Epidemiology animal disease
 
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
OS20 - Effective risk communication ​for animal disease emergencies - Lisa Bo...
 
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health Examples
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health ExamplesDr. Lauri Hicks - One Health Antibiotic Stewardship Human Health Examples
Dr. Lauri Hicks - One Health Antibiotic Stewardship Human Health Examples
 
Formulating Institutional Antibiotic Policy
Formulating Institutional Antibiotic PolicyFormulating Institutional Antibiotic Policy
Formulating Institutional Antibiotic Policy
 
Outbreak Investigation of Healthcare Associated Infections
Outbreak Investigation of Healthcare Associated InfectionsOutbreak Investigation of Healthcare Associated Infections
Outbreak Investigation of Healthcare Associated Infections
 
The WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDsThe WHO/WPPRO Preparedness Strategy for EIDs
The WHO/WPPRO Preparedness Strategy for EIDs
 
PIDSR
PIDSRPIDSR
PIDSR
 
Infection Control and Antibiotic Stewardship
Infection Control and Antibiotic StewardshipInfection Control and Antibiotic Stewardship
Infection Control and Antibiotic Stewardship
 
Antimicrobial Stewardship Program
Antimicrobial Stewardship ProgramAntimicrobial Stewardship Program
Antimicrobial Stewardship Program
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
 
The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...
The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...
The Prick will do the Trick: Protecting our Healthcare Workers from Vaccine-P...
 
Pharmacy
PharmacyPharmacy
Pharmacy
 
Using one health and participatory epidemiology to assess impacts of anthrax ...
Using one health and participatory epidemiology to assess impacts of anthrax ...Using one health and participatory epidemiology to assess impacts of anthrax ...
Using one health and participatory epidemiology to assess impacts of anthrax ...
 

Similar to Raman Velayudhan-Enfermedades transmitidas por vectores

Dengue prevention & control
Dengue prevention & controlDengue prevention & control
Dengue prevention & control
Geetha Mani
 
State of foot-and-mouth disease research
State of foot-and-mouth disease researchState of foot-and-mouth disease research
State of foot-and-mouth disease research
ILRI
 
Dengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptxDengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptx
asifmehmood227390
 
Dengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptxDengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptx
asifmehmood227390
 
Vector Borne Diseases - The Growing Menace
Vector Borne Diseases - The Growing MenaceVector Borne Diseases - The Growing Menace
Vector Borne Diseases - The Growing Menace
Rakshit S
 
Emerging Infectious Disease (EID) Preparedness
Emerging Infectious Disease (EID) PreparednessEmerging Infectious Disease (EID) Preparedness
Emerging Infectious Disease (EID) Preparedness
SamahAbdelaal
 
INTEGRATED VECTOR MANAGEMENT ………...pptx
INTEGRATED VECTOR  MANAGEMENT ………...pptxINTEGRATED VECTOR  MANAGEMENT ………...pptx
INTEGRATED VECTOR MANAGEMENT ………...pptx
76dpk7z99b
 
Animal Disease Control
Animal Disease ControlAnimal Disease Control
Animal Disease Control
Perez Eric
 
Controlling infectious diseases
Controlling infectious diseasesControlling infectious diseases
Controlling infectious diseases
DancinGStarr
 
Dengue part 2- emerging public health problem
Dengue part 2- emerging public health problemDengue part 2- emerging public health problem
Dengue part 2- emerging public health problemDr Kaushik Narayan
 
Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica
UWI_Markcomm
 
Pathogen discovery platform
Pathogen discovery platformPathogen discovery platform
Pathogen discovery platform
ILRI
 
IPC, Infection prevention and Control; By Dechasa Adare Mengistu; ppt
IPC, Infection prevention and Control; By Dechasa Adare Mengistu; pptIPC, Infection prevention and Control; By Dechasa Adare Mengistu; ppt
IPC, Infection prevention and Control; By Dechasa Adare Mengistu; ppt
DechasaAdare
 
infectious-disease-management-presentation-slides.pptx
infectious-disease-management-presentation-slides.pptxinfectious-disease-management-presentation-slides.pptx
infectious-disease-management-presentation-slides.pptx
EugenieLakatos
 
Vector borne program
Vector borne programVector borne program
Vector borne program
KULDEEP VYAS
 
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMMENATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
MAHESWARI JAIKUMAR
 
Risk management: Part 2
Risk management: Part 2Risk management: Part 2
Risk management: Part 2
ILRI
 
Concepts of infection control
Concepts of infection control  Concepts of infection control
Concepts of infection control
Anjum Hashmi MPH
 
Threats and preventions of bioterrorism
Threats and preventions of bioterrorismThreats and preventions of bioterrorism
Threats and preventions of bioterrorismNida Sajjad
 
Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...
Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...
Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...
John Blue
 

Similar to Raman Velayudhan-Enfermedades transmitidas por vectores (20)

Dengue prevention & control
Dengue prevention & controlDengue prevention & control
Dengue prevention & control
 
State of foot-and-mouth disease research
State of foot-and-mouth disease researchState of foot-and-mouth disease research
State of foot-and-mouth disease research
 
Dengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptxDengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptx
 
Dengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptxDengue Vector surveillance Pakistan.pptx
Dengue Vector surveillance Pakistan.pptx
 
Vector Borne Diseases - The Growing Menace
Vector Borne Diseases - The Growing MenaceVector Borne Diseases - The Growing Menace
Vector Borne Diseases - The Growing Menace
 
Emerging Infectious Disease (EID) Preparedness
Emerging Infectious Disease (EID) PreparednessEmerging Infectious Disease (EID) Preparedness
Emerging Infectious Disease (EID) Preparedness
 
INTEGRATED VECTOR MANAGEMENT ………...pptx
INTEGRATED VECTOR  MANAGEMENT ………...pptxINTEGRATED VECTOR  MANAGEMENT ………...pptx
INTEGRATED VECTOR MANAGEMENT ………...pptx
 
Animal Disease Control
Animal Disease ControlAnimal Disease Control
Animal Disease Control
 
Controlling infectious diseases
Controlling infectious diseasesControlling infectious diseases
Controlling infectious diseases
 
Dengue part 2- emerging public health problem
Dengue part 2- emerging public health problemDengue part 2- emerging public health problem
Dengue part 2- emerging public health problem
 
Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica Zika Prevention Approaches in Jamaica
Zika Prevention Approaches in Jamaica
 
Pathogen discovery platform
Pathogen discovery platformPathogen discovery platform
Pathogen discovery platform
 
IPC, Infection prevention and Control; By Dechasa Adare Mengistu; ppt
IPC, Infection prevention and Control; By Dechasa Adare Mengistu; pptIPC, Infection prevention and Control; By Dechasa Adare Mengistu; ppt
IPC, Infection prevention and Control; By Dechasa Adare Mengistu; ppt
 
infectious-disease-management-presentation-slides.pptx
infectious-disease-management-presentation-slides.pptxinfectious-disease-management-presentation-slides.pptx
infectious-disease-management-presentation-slides.pptx
 
Vector borne program
Vector borne programVector borne program
Vector borne program
 
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMMENATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME
 
Risk management: Part 2
Risk management: Part 2Risk management: Part 2
Risk management: Part 2
 
Concepts of infection control
Concepts of infection control  Concepts of infection control
Concepts of infection control
 
Threats and preventions of bioterrorism
Threats and preventions of bioterrorismThreats and preventions of bioterrorism
Threats and preventions of bioterrorism
 
Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...
Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...
Dr. Jeff Bender - One Health Antibiotic Stewardship Science and Practice - Wh...
 

More from Fundación Ramón Areces

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Fundación Ramón Areces
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Fundación Ramón Areces
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London.
Fundación Ramón Areces
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Fundación Ramón Areces
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Fundación Ramón Areces
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Fundación Ramón Areces
 
Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.
Fundación Ramón Areces
 
Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School. Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School.
Fundación Ramón Areces
 
Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School. Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School.
Fundación Ramón Areces
 
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Fundación Ramón Areces
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Fundación Ramón Areces
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Fundación Ramón Areces
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Fundación Ramón Areces
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster.
Fundación Ramón Areces
 
Mercedes Ayuso - Universitat de Barcelona.
Mercedes Ayuso -  Universitat de Barcelona. Mercedes Ayuso -  Universitat de Barcelona.
Mercedes Ayuso - Universitat de Barcelona.
Fundación Ramón Areces
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Fundación Ramón Areces
 
Julia Campa - The Open University.
Julia Campa - The Open University. Julia Campa - The Open University.
Julia Campa - The Open University.
Fundación Ramón Areces
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico.
Fundación Ramón Areces
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Fundación Ramón Areces
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven.
Fundación Ramón Areces
 

More from Fundación Ramón Areces (20)

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London.
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
 
Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.
 
Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School. Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School.
 
Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School. Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School.
 
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster.
 
Mercedes Ayuso - Universitat de Barcelona.
Mercedes Ayuso -  Universitat de Barcelona. Mercedes Ayuso -  Universitat de Barcelona.
Mercedes Ayuso - Universitat de Barcelona.
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
 
Julia Campa - The Open University.
Julia Campa - The Open University. Julia Campa - The Open University.
Julia Campa - The Open University.
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico.
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven.
 

Recently uploaded

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 

Recently uploaded (20)

Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 

Raman Velayudhan-Enfermedades transmitidas por vectores

  • 1. Vector control research needs for NTDs Dr Raman Velayudhan, Coordinator, Vector Ecology and Management, NTD
  • 2. Challenges of Vector Control  Lack of resources  Very often used as a last resort Equipment's and plans are developed after the outbreak is underway A delay of over a week makes control ineffective  Decentralization of health services Trained staff Procurement of appropriate interventions Lack of routine vector surveillance  Urban vector control Delivery/Responsibility Community involvement Often blamed for failure
  • 3. Aedes aegypti and Aedes albopictus
  • 4. Knowledge & Research Gaps for Dengue Vector Control • Why is disease burden increasing? Unsuccessful programs: Lack of resources, lack of political will or ineffective implementation Also responsible: Deficiencies in understanding virus transmission, methods for assessing & responding to risk & failure to effectively use surveillance data for control decisions Knowledge & research gaps: • Entomological measures of risk • Epidemiologic impact of vector interventions • Insecticide resistance: monitor & manage • Spatial scales that characterize transmission • Dynamic responses to control • Research design for VC
  • 5. Urban, semi-urban and rural movement • Human movement – critical and understudied component in transmission • Facilitate identification of hot spots, prompt response and suppress outbreaks • Surveillance, intervention and prevention • Points of entry needs to be monitored for vectors under IHR (2005)
  • 6. A Critical Assessment of Vector Control for Dengue Prevention NL Achee, F Gould, TA Perkins, RC Reiner, Jr., AC Morrison, S Richie, DJ Gubler, and TW Scott
  • 7. HAT and vector • Vector borne disease, transmitted by glossina genus (tsetse fly) • Main species involved: • Gambiense HAT: G. palpalis, G. fuscipes • Rhodesiense HAT: G. morsitans, G. fuscipes, G. pallidipes, G. Swynnetoni
  • 8. HAT vector control • Multiple vector control methods available, to be adapted to different epidemiological settings Ground spraying Aerial spraying Sterile insects release Mobile baits Natural baits Protective fences Artificial baits Repellents
  • 9. Rhodesiense HAT and vector control • Rhodesiense HAT is a zoonotic disease where wildlife and domestic animals are the main reservoirs. Vector control and treatment of infected animals when possible are key elements for controlling the disease. • Vector control has successfully used in some Rhodesian HAT foci. Successes were achieved through large-scale operations, expensive and requiring strong vector control departments • Current vector control tools are highly variable in characteristics and quality (Fabrics, colors, insecticide loading and release,…). Target product profiles of these tools tailored to different environments are needed. • It is needed to improve the evidence-based knowledge for countries to make decisions on which tools to use in different settings, and how to use them most effectively.
  • 10. Elimination of intra-domiciliary vectorial transmission of Chagas disease in Latin America (2020) Control of vectorial transmission by August 2015 0 5,000,000 10,000,000 15,000,000 20,000,000 25,000,000 30,000,000 WHO1960 WHO1976 WHO1981 PAHO1984 Walsh1984 WHO1985 WHO1990 WHO1991 WHO1992 PAHO1994 Schmunis1999 Schmunis1999 Schmunis2000 WorlBank/DCPP2006 PAHO/WHO2006 WHO2010 WHO2013 WHO2014 Series1 Latin American Initiatives Non endemic coutries Initiative • 3 hot control areas remaining: Gran Chaco, El Salvador/Guatemala & Amazon basin
  • 11.
  • 12. Network to monitor triatomine bug resistance to insecticides – REMOT
  • 13. What tools/approaches are available for tackling exophilic and exophagic sandflies? 1. Treating other main sources of bloodmeals with systemic insecticides (endectocides), such as fipronil and imidacloprid. 2. Exploiting sugar-feeding behaviour of vectors to develop attractive toxic sugar baits (ATSBs) 3. Environmental Control 4. Developing insecticide-impregnated or repellent- impregnated products to be used by specific communities. 5. Pheromones? 6. Genetic Control? (e.g. SIT: sterile insect technique)
  • 14. Integrated Vector Management A rational decision-making process for optimal use of resources for vector control How do we operationalize IVM?
  • 15. Framework for planning & implementation 2. Selection of vector control methods 3. Needs & resources 4. Implementation 5. Monitoring & evaluation Disease situation • Integrated surveillance Vector, cases, lab • Vector assessment • Epidemiological assessment • Stratification • Local determinants of disease Diseases specific reporting needs
  • 16. Conclusion  Current tools & strategies have not been evaluated adequately for disease impact (epidemiologic outcomes)  There is current research on new tools/strategies, but little support for improving delivery & coverage of vector control  The biggest gap in current vector control for is how much coverage is necessary for disease reduction goals  General consensus is that 1 approach will not solve the problem by itself, we need to use a combination of approaches  Vector control & vaccines: How exactly should this be done?  Urban health and delivery of services needs to be addressed  Sustained vector control interventions needs to be promoted